• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒复制能力基因组长度对不同抗原分泌的影响。

Impact of length of replication competent genome of hepatitis B virus over the differential antigenic secretion.

机构信息

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.

Department of Biosciences, Jamia Millia Islamia, New Delhi, India.

出版信息

J Cell Biochem. 2019 Oct;120(10):17858-17871. doi: 10.1002/jcb.29054. Epub 2019 Jul 16.

DOI:10.1002/jcb.29054
PMID:31310366
Abstract

Hepatitis B virus (HBV) genome consists of circular partially double stranded DNA of 3.2 kb size which gets converted into covalently closed circular DNA (cccDNA) during its life cycle. It then acts as a template for formation of pregenomicRNA (pgRNA) of 3.5 kb. Absence of appropriate animal models prompted a need to establish a better in vitro culture system to uncover the propagation and survival mechanisms of the virus. There is scarcity of data to represent the significance of varying length of replication competent viral genome on the secretion of viral secretory proteins/antigens and in turn on the overall effects on the accomplishment of the viral life cycle. The present study was undertaken to ascertain a suitable replication competent construct in which the viral life cycle of HBV with varying clinical relevance can be studied efficiently. Two constructs (pHBV 1.3 and pHBV 1X) of different sizes were used to transfect hepatoma cells and consequently the secretory antigens were monitored. In vector free approach (pHBV 1X), 3.2 kb viral DNA is directly transfected in the culture system whereas in vector mediated approach more than full length of viral genome is cloned in a vector (pHBV 1.3X) and transfected to obtain a 3.5 kb pgRNA intermediate. HBV secretes two important antigens; HBsAg and HBeAg. HBsAg is a hallmark of infection and is the first to be secreted in the blood stream whereas HBeAg is a secretory protein and remains associated with the viral replication. The construct pHBV 1.3X referring to as more than full length, by virtue of being capable of undergoing transcription without the synthesis of cccDNA intermediate (unlike the clinical situation where an intermediate step of cccDNA synthesis is an essential component to initiate the viral life cycle) appears to be better system for studying viral life cycle in in vitro culture system. The reasons could be assigned to the fact that as low as 100 ng of viral DNA was shown to quantify the replicative phenotypes with this construct. The better efficiency of this construct at prima facie, appears to be mediated through the significantly higher levels of pgRNA transcript during the viral life cycle.

摘要

乙型肝炎病毒 (HBV) 基因组由大小为 3.2kb 的环状部分双链 DNA 组成,在其生命周期中转化为共价闭合环状 DNA (cccDNA)。然后,它作为形成 3.5kb 前基因组 RNA (pgRNA)的模板。由于缺乏适当的动物模型,需要建立更好的体外培养系统来揭示病毒的繁殖和生存机制。缺乏数据来代表具有不同长度的复制能力病毒基因组对病毒分泌蛋白/抗原的分泌的重要性,以及对病毒生命周期完成的整体影响。本研究旨在确定一种合适的复制能力构建体,以便有效地研究具有不同临床相关性的 HBV 病毒生命周期。使用两种不同大小的构建体 (pHBV 1.3 和 pHBV 1X) 转染肝癌细胞,随后监测分泌抗原。在无载体方法 (pHBV 1X) 中,3.2kb 病毒 DNA 直接转染到培养系统中,而在载体介导方法中,将超过全长的病毒基因组克隆到载体 (pHBV 1.3X) 中并转染以获得 3.5kb pgRNA 中间体。HBV 分泌两种重要的抗原;HBsAg 和 HBeAg。HBsAg 是感染的标志,是第一个在血液中分泌的,而 HBeAg 是一种分泌蛋白,与病毒复制相关。构建体 pHBV 1.3X 被称为全长,由于能够在不合成 cccDNA 中间体的情况下进行转录(与临床情况不同,cccDNA 合成的中间步骤是启动病毒生命周期的必要组成部分),因此似乎是体外培养系统中研究病毒生命周期的更好系统。原因可能归因于这样一个事实,即仅用 100ng 病毒 DNA 即可定量该构建体的复制表型。这个构建体的效率更高,这似乎是通过在病毒生命周期中 pgRNA 转录的水平显著提高来介导的。

相似文献

1
Impact of length of replication competent genome of hepatitis B virus over the differential antigenic secretion.乙型肝炎病毒复制能力基因组长度对不同抗原分泌的影响。
J Cell Biochem. 2019 Oct;120(10):17858-17871. doi: 10.1002/jcb.29054. Epub 2019 Jul 16.
2
Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.前基因组 RNA 启动乙型肝炎病毒复制系统有助于研究共价闭合环状 DNA 合成中抗病毒药物和耐药变异体的作用机制。
J Virol. 2022 Dec 21;96(24):e0115022. doi: 10.1128/jvi.01150-22. Epub 2022 Nov 30.
3
Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.乙型肝炎病毒 DNA 水平在 HBeAg 血清学转换时下降主要是由于 cccDNA 载量减少所致——PgRNA 转录下调的影响有限。
PLoS One. 2012;7(7):e36349. doi: 10.1371/journal.pone.0036349. Epub 2012 Jul 20.
4
Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication.自然发生的 PreS1 缺失突变乙型肝炎病毒的丢失小信封蛋白表达通常伴随着 HBx 和核心蛋白表达以及基因组复制的增加。
J Virol. 2021 Jun 24;95(14):e0066021. doi: 10.1128/JVI.00660-21.
5
[An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].[用环状病毒DNA转染原代大鼠肝细胞建立乙肝病毒基因复制与表达的体外模型]
Zhonghua Gan Zang Bing Za Zhi. 2002 Aug;10(4):275-8.
6
Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.在慢性乙型肝炎病毒感染中,逆转录下游机制可降低血清中乙肝病毒DNA水平,但不能降低乙肝表面抗原水平。
Virol J. 2015 Dec 9;12:213. doi: 10.1186/s12985-015-0447-5.
7
Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.慢性感染患者肝内共价闭合环状乙型肝炎病毒DNA的水平及复制活性
Hepatology. 2006 Sep;44(3):694-702. doi: 10.1002/hep.21299.
8
Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.没食子酸表没食子儿茶素酯可抑制病毒复制诱导细胞系中的 HBV DNA 合成。
World J Gastroenterol. 2011 Mar 21;17(11):1507-14. doi: 10.3748/wjg.v17.i11.1507.
9
Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication.乙肝病毒编码的微小RNA控制病毒复制。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.01919-16. Print 2017 May 15.
10
Intracellular Trafficking of HBV Particles.HBV 颗粒的细胞内运输。
Cells. 2020 Sep 2;9(9):2023. doi: 10.3390/cells9092023.

引用本文的文献

1
Inhibition of Hepatitis B Virus (HBV) by Tachyplesin, a Marine Antimicrobial Cell-Penetrating Peptide.海洋抗菌细胞穿透肽鲎素对乙型肝炎病毒(HBV)的抑制作用
Pharmaceutics. 2023 Feb 16;15(2):672. doi: 10.3390/pharmaceutics15020672.
2
Biological Characterization of Hepatitis B virus Genotypes: Their Role in Viral Replication and Antigen Expression.乙型肝炎病毒基因型的生物学特性:它们在病毒复制和抗原表达中的作用
Front Microbiol. 2021 Nov 4;12:758613. doi: 10.3389/fmicb.2021.758613. eCollection 2021.
3
A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus.
一种新型哌嗪衍生物能有效靶向乙型肝炎表面抗原,抑制耐替诺福韦的乙型肝炎病毒。
Sci Rep. 2021 Jun 3;11(1):11723. doi: 10.1038/s41598-021-91196-1.
4
MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.微小 RNA-1271-5p 通过与水通道蛋白 5 结合缓解乙型肝炎病毒介导的肝癌的恶性发展。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.12025. Epub 2021 Mar 24.